Oral Paclitaxel Trial In Recurrent and Metastatic Breast Cancer As 1st Line Therapy

NCT03315364 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

549

Enrollment

INDUSTRY

Sponsor class

Conditions

Recurrent or Metastatic Breast Cancer

Interventions

DRUG: Oral paclitaxel
DRUG: Paclitaxel injection

Sponsor

Daehwa Pharmaceutical Co., Ltd.